| Casey Hay, MD | |
|
101 W 8th Ave Ste 1400, Spokane, WA 99204-2307 | |
| (509) 474-2200 | |
| (509) 474-2737 |
| Full Name | Casey Hay |
|---|---|
| Gender | Female |
| Speciality | Obstetrics/gynecology |
| Experience | 13 Years |
| Location | 101 W 8th Ave Ste 1400, Spokane, Washington |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053607523 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Prov Sacred Hrt Med Ctr & Childs Hosp. | Spokane, WA | Hospital |
| Providence Holy Family Hospital | Spokane, WA | Hospital |
| St Joseph Regional Medical Center | Lewiston, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 0345139929 | 687 |
News Archive
Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
After a prolonged decline, global hunger is on the rise-affecting more than 820 million individuals in 2017. Additionally, more than 2 billion people suffer from "hidden hunger," which occurs when individuals eat foods that don't provide the nutrients they need to lead healthy, productive lives.
It is the cosmetic treatment many women have dreamed of - taking the fat from their hips and thighs and redistributing it to their breasts. But many people question whether this procedure is safe or effective.
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
› Verified 1 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1194099390 PECOS PAC ID: 0345139929 Enrollment ID: O20040311001453 |
News Archive
Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
After a prolonged decline, global hunger is on the rise-affecting more than 820 million individuals in 2017. Additionally, more than 2 billion people suffer from "hidden hunger," which occurs when individuals eat foods that don't provide the nutrients they need to lead healthy, productive lives.
It is the cosmetic treatment many women have dreamed of - taking the fat from their hips and thighs and redistributing it to their breasts. But many people question whether this procedure is safe or effective.
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Casey Hay, MD 101 W 8th Ave Ste 1400, Spokane, WA 99204-2307 Ph: (509) 474-2200 | Casey Hay, MD 101 W 8th Ave Ste 1400, Spokane, WA 99204-2307 Ph: (509) 474-2200 |
News Archive
Celgene International Sàrl today announced that results from a clinical study of ABRAXANE in combination with gemcitabine in 67 patients with previously untreated advanced pancreatic cancer were published in an online article by the Journal of Clinical Oncology ahead of print.
The combination of estrogen plus progestin, which women stopped taking in droves following the news that it may increase their risk of breast cancer, may decrease their risk of colorectal cancer, according to a report published in the January issue of Cancer Epidemiology, Biomarkers and Prevention , a journal of the American Association for Cancer Research.
After a prolonged decline, global hunger is on the rise-affecting more than 820 million individuals in 2017. Additionally, more than 2 billion people suffer from "hidden hunger," which occurs when individuals eat foods that don't provide the nutrients they need to lead healthy, productive lives.
It is the cosmetic treatment many women have dreamed of - taking the fat from their hips and thighs and redistributing it to their breasts. But many people question whether this procedure is safe or effective.
Bristol-Myers Squibb Company and Pfizer today announced that the companies have agreed to stop the Phase 3 AVERROES clinical trial of apixaban in patients with atrial fibrillation. The study will be stopped early because a predefined interim analysis by the independent Data Monitoring Committee (DMC) revealed clear evidence of a clinically important reduction in stroke and systemic embolism in patients with atrial fibrillation considered intolerant of or unsuitable for vitamin K antagonist therapy who received apixaban as compared to aspirin.
› Verified 1 days ago
Karla E Khan, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 235 E Rowan Ave, Ste 102, Spokane, WA 99207 Phone: 509-489-2101 Fax: 509-462-4949 | |
Dr. Craig M. Smentek, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 32 W 2nd Ave, Spokane, WA 99201 Phone: 509-626-9825 Fax: 509-227-7070 | |
Dr. Dawn Michelle Kopp, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 101 W 8th Ave Ste 1100, Spokane, WA 99204 Phone: 509-474-4060 Fax: 509-227-7070 | |
Kristian Enghusen, OMS IV Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 322 W North River Dr, Spokane, WA 99201 Phone: 509-324-6464 Fax: 509-241-2056 | |
Dr. Abigail Rose Prest, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 212 E Central Ave Ste 340, Spokane, WA 99208 Phone: 509-484-1236 | |
Mr. Robert F Sestero, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 820 S Mcclellan St, #116, Spokane, WA 99204 Phone: 509-838-4211 Fax: 509-838-6432 |